India to Turkey: Ibrutinib Export Trade Route

The India to Turkey Ibrutinib corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $41.5K USD. The route is dominated by ROYAL MEDICAL PRIVATE LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $1.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 18.5%, placing it at rank #19 among India's top ibrutinib export destinations globally.

On the import side, key buyers of Indian ibrutinib in Turkey include TO THE ORDER OF INVOICE RAISED TO, SLO TIBBI ILAC ITHALAT, TO THE ORDER OF INVOICE and 11 others. TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 9 shipments valued at $15.5K USD.

India's ibrutinib exports to Turkey are driven primarily by a handful of large-scale manufacturers. ROYAL MEDICAL PRIVATE LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED, RMPL PHARMA LLP, M T MADON EXPORTS — together account for 63% of total trade value on this route. The average shipment value of $1.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as nitib 140 mg 30cap ibrutinib and nitib 140mg capsule[150 nos x 30 = 4500tab ]each tab cont ibrutinib 140mgnos, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer with 9 shipments worth $15.5K USD — representing 37% of all ibrutinib imports from India on this route. A total of 14 buyers are active on this corridor.